Authors:
WELLS DA
SALE GE
SHULMAN HM
MYERSON D
BRYANT EM
GOOLEY T
LOKEN MR
Citation: Da. Wells et al., MULTIDIMENSIONAL FLOW-CYTOMETRY OF MARROW CAN DIFFERENTIATE LEUKEMIC FROM NORMAL LYMPHOBLASTS AND MYELOBLASTS AFTER CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION, AJCP. American journal of clinical pathology, 110(1), 1998, pp. 84-94
Authors:
ROWLEY SD
LOKEN M
RADICH J
KUNKLE LA
MILLS BJ
GOOLEY T
HOLMBERG L
MCSWEENEY P
BEACH K
MACLEOD B
APPELBAUM F
BENSINGER WI
Citation: Sd. Rowley et al., ISOLATION OF CD34(-CELL COMPONENTS USING THE BAXTER ISOLEX SYSTEM() CELLS FROM BLOOD STEM), Bone marrow transplantation, 21(12), 1998, pp. 1253-1262
Authors:
MCDONALD GB
BOUVIER M
HOCKENBERY DM
STERN JM
GOOLEY T
FARRAND A
MURAKAMI C
LEVINE DS
Citation: Gb. Mcdonald et al., ORAL BECLOMETHASONE DIPROPIONATE FOR TREATMENT OF INTESTINAL GRAFT-VERSUS-HOST DISEASE - A RANDOMIZED, CONTROLLED TRIAL, Gastroenterology, 115(1), 1998, pp. 28-35
Authors:
MORTON AJ
GOOLEY T
HANSEN JA
APPELBAUM FR
BRUEMMER B
BJERKE JW
CLIFT R
MARTIN PJ
PETERSDORF EW
SANDERS JE
STORB R
SULLIVAN KM
WOOLFREY A
ANASETTI C
Citation: Aj. Morton et al., ASSOCIATION BETWEEN PRETRANSPLANT INTERFERON-ALPHA AND OUTCOME AFTER UNRELATED DONOR MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE, Blood, 92(2), 1998, pp. 394-401
Authors:
STOREK J
GOOLEY T
WITHERSPOON RP
SULLIVAN KM
STORB R
Citation: J. Storek et al., INFECTIOUS MORBIDITY IN LONG-TERM SURVIVORS OF ALLOGENEIC MARROW TRANSPLANTATION IS ASSOCIATED WITH LOW CD4 T-CELL COUNTS, American journal of hematology, 54(2), 1997, pp. 131-138
Authors:
SCHUENING FG
VONKALLE C
KIEM HP
APPELBAUM FR
DEEG HJ
PEPE M
GOOLEY T
GRAHAM TC
HACKMAN RC
STORB R
Citation: Fg. Schuening et al., EFFECT OF RECOMBINANT CANINE STEM-CELL FACTOR, A C-KIT LIGAND, ON HEMATOPOIETIC RECOVERY AFTER DLA-IDENTICAL LITTERMATE MARROW TRANSPLANTS IN DOGS, Experimental hematology, 25(12), 1997, pp. 1240-1245
Authors:
LEE JL
GOOLEY T
BENSINGER W
SCHIFFMAN K
MCDONALD GB
Citation: Jl. Lee et al., VENOCCLUSIVE DISEASE OF THE LIVER AFTER HIGH-DOSE CHEMOTHERAPY WITH ALKYLATING-AGENTS - INCIDENCE, OUTCOME, AND RISK-FACTORS, Hepatology, 26(4), 1997, pp. 83-83
Authors:
KO CW
GOOLEY T
SCHOCH HG
MYERSON D
HACKMAN RC
SHULMAN HM
SALE GE
LEE SP
MCDONALD GB
Citation: Cw. Ko et al., ACUTE-PANCREATITIS IN MARROW TRANSPLANT PATIENTS - PREVALENCE AT AUTOPSY AND RISK FACTOR-ANALYSIS, Bone marrow transplantation, 20(12), 1997, pp. 1081-1086
Authors:
MCDONALD GB
BOUVIER M
STERN JG
GOOLEY T
FARRAND A
LEVINE DS
Citation: Gb. Mcdonald et al., A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF ORAL BECLOMETHASONE DIPROPIONATE FOR TREATMENT OF INTESTINAL GRAFT-VS-HOST DISEASE, Gastroenterology, 112(4), 1997, pp. 1037-1037
Authors:
TOROKSTORB B
BOECKH M
HOY C
LEISENRING W
MYERSON D
GOOLEY T
Citation: B. Torokstorb et al., ASSOCIATION OF SPECIFIC CYTOMEGALOVIRUS GENOTYPES WITH DEATH FROM MYELOSUPPRESSION AFTER MARROW TRANSPLANTATION, Blood, 90(5), 1997, pp. 2097-2102
Authors:
STOREK J
GOOLEY T
SIADAK M
BENSINGER WI
MALONEY DG
CHAUNCEY TR
FLOWERS M
SULLIVAN KM
WITHERSPOON RP
ROWLEY SD
HANSEN JA
STORB R
APPELBAUM FR
Citation: J. Storek et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION MAY BE ASSOCIATED WITH A HIGH-RISK OF CHRONIC GRAFT-VERSUS-HOST DISEASE, Blood, 90(12), 1997, pp. 4705-4709
Authors:
CHAUNCEY TR
THOMPSON AR
STEWART L
GOOLEY T
MCDONALD GB
Citation: Tr. Chauncey et al., NO ASSOCIATION BETWEEN ACTIVATED PROTEIN-C (APC) RESISTANCE AND HEPATIC VENOOCCLUSIVE DISEASE (VOD) FOLLOWING STEM-CELL TRANSPLANTATION, Blood, 90(10), 1997, pp. 4353-4353
Authors:
MORTON AJ
GOOLEY T
HANSEN JA
APPELBAUM FR
BJERKE JW
CLIFT R
MARTIN PJ
PETERSDORF EW
SANDERS JE
STORB R
SULLIVAN KM
ANASETTI C
Citation: Aj. Morton et al., IMPACT OF PRETRANSPLANT INTERFERON-ALPHA (IFN-ALPHA) ON OUTCOME OF UNRELATED DONOR MARROW TRANSPLANTS FOR CHRONIC MYELOID-LEUKEMIA (CML) INFIRST CHRONIC PHASE, Blood, 90(10), 1997, pp. 536-536
Authors:
SLATTERY JT
CLIFT RA
BUCKNER CD
RADICH J
STORER B
BENSINGER WI
SOLL E
ANASETTI C
BOWDEN R
BRYANT E
CHAUNCEY T
DEEG HJ
DONEY KC
FLOWERS M
GOOLEY T
HANSEN JA
MARTIN PJ
MCDONALD GB
NASH R
PETERSDORF EW
SANDERS JE
SCHOCH G
STEWART P
STORB R
SULLIVAN KM
THOMAS ED
WITHERSPOON RP
APPELBAUM FR
Citation: Jt. Slattery et al., MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE INFLUENCE OF PLASMA BUSULFAN LEVELS ON THE OUTCOME OF TRANSPLANTATION, Blood, 89(8), 1997, pp. 3055-3060
Authors:
RADICH J
GEHLY G
LEE A
AVERY R
BRYANT E
EDMANDS S
GOOLEY T
KESSLER P
KIRK J
LADNE P
THOMAS ED
APPELBAUM FR
Citation: J. Radich et al., DETECTION OF BCR-ABL TRANSCRIPTS IN PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA AFTER MARROW TRANSPLANTATION, Blood, 89(7), 1997, pp. 2602-2609
Authors:
NELSON JL
FURST DE
MALONEY S
EVANS PC
STOREK J
BEAN MA
OBER C
SMITH A
GOOLEY T
BIANCHI DW
Citation: Jl. Nelson et al., MICROCHIMERISM AND HLA-COMPATIBLE RELATIONSHIPS OF PREGNANCY IN WOMENWITH SCLERODERMA, Arthritis and rheumatism, 40(9), 1997, pp. 1007-1007
Citation: Ra. Nash et al., THE PROBLEM OF THROMBOCYTOPENIA AFTER HEMATOPOIETIC STEM-CELL TRANSPLANTATION (VOL 14, PG 261, 1996), Stem cells, 14(6), 1996, pp. 743-743
Authors:
ANDERSON JE
APPELBAUM FR
SCHOCH G
GOOLEY T
ANASETTI C
BENSINGER WI
BRYANT E
BUCKNER CD
CHAUNCEY T
CLIFT RA
DEEG HJ
DONEY K
FLOWERS M
HANSEN JA
MARTIN PJ
MATTHEWS DC
NASH RA
SANDERS JE
SHULMAN H
SULLIVAN KM
WITHERSPOON RP
STORB R
Citation: Je. Anderson et al., ALLOGENEIC MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME WITH ADVANCED DISEASE MORPHOLOGY - A PHASE-II STUDY OF BUSULFAN, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION AND ANALYSIS OF PROGNOSTIC FACTORS, Journal of clinical oncology, 14(1), 1996, pp. 220-226
Authors:
ANASETTI C
GOOLEY T
CLIFT R
PETERSDORF E
MARTIN P
HANSEN J
Citation: C. Anasetti et al., UNRELATED DONOR MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA (CML), Experimental hematology, 24(9), 1996, pp. 724-724
Authors:
HUSS R
DEEG HJ
GOOLEY T
BRYANT E
LEISENRING W
CLIFT R
BUCKNER CD
MARTIN P
STORB R
APPELBAUM FR
Citation: R. Huss et al., EFFECT OF MIXED CHIMERISM ON GRAFT-VERSUS-HOST DISEASE, DISEASE RECURRENCE AND SURVIVAL AFTER HLA-IDENTICAL MARROW TRANSPLANTATION FOR APLASTIC-ANEMIA OR CHRONIC MYELOGENOUS LEUKEMIA, Bone marrow transplantation, 18(4), 1996, pp. 767-776